Tresto E-Gen (Ment)

Tresto E-Gen (Ment) 100 mg 10 ml
Qty:TotalItem priceSaving
1 vial $95.00 $95.00 -

Tresto E-Gen (Ment) is a product which contains 100 mg per ML of the hormone Trestolone Enanthate.
Tresto E-Gen (Ment) 100, also known as 7α-methyl-19-nortestosterone 17β-enanthate (MENT Enanthate), is an androgen and anabolic steroid (AAS) and progestogen.

It is an androgen ester; specifically, it is the C17β enanthate (heptanoate) ester of trestolone (7α-methylestr-4-en-17β-ol-3-one). Trestolone Enanthate has low affinity for sex hormone-binding globulin (SHBG), similarly to Testosterone Enanthate.

Also Tresto E-Gen provides adequate replacement therapy for most androgen-dependant functions. Tresto E-Gen has a faster metabolic clearance rate than Testosterone and does not bind to sex hormone binding globulin. Tresto E-Gen (Ment) remains capable of aromatization preserving the benefits estrogen imparts on male physiology.

Tresto E-Gen is very aromatizing and will cause synthetic estrogen buildup which will carry high biological activity.  The side effects of Tresto E-Gen are the same for this as with Nandrolone. The most common side effects of Tresto E-Gen are gynecomastia, hair loss, acne, prostate hypertrophy, deepending of voice, clitoris enlargement for women. Excess water retention can cause the user to have a bloated look without much definition to the muscle structure. Tresto E-Gen can also lead for excess fat buildup to occur. The one thing that is not a side effect, as is the case with many Nandrolone derivatives, is libido suppression. Because of this side effects, users of Enanthate is necessary to use anti-estrogens during their cycle to keep levels down.

A low dose of Tresto E-Gen will be sufficient due to the fact that Tresto E-Gen has been shown to be several times more potent than Testosterone. The form of Trestolone Enanthate works slower and leaves the body slower as well.

In order to add review, please log in

No review yet

To ask or answer questions, please register or log in an account.

No questions yet